SHANNON KIMSEY: Open Payments
NPI 1023448073 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,957 in 101 payments from 16 companies in 2025. Trend: 2023 $1,776 · 2024 $1,280 · 2025 $1,957
Food & beverage: $1,674Education: $283
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $348 |
| Janssen Biotech, Inc. | 13 | $334 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $282 |
| ABBVIE INC. | 19 | $270 |
| Novartis Pharmaceuticals Corporation | 11 | $212 |
| Regeneron Healthcare Solutions, Inc. | 2 | $124 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $69 |
| Almirall LLC | 2 | $67 |
| Organon LLC | 4 | $60 |
| Lilly USA, LLC | 2 | $56 |
Products named: Bimzelx, TREMFYA, ILUMYA, DUPIXENT, COSENTYX, SKYRIZI, RINVOQ, BOTOX.
Industry payments across IL — which companies pay providers there.
